Skip to main content

Table 3 Comparison of ARB, SMM-align and PROPRED's performance on current and old dataset.

From: Peptide binding predictions for HLA DR, DP and DQ molecules

Allelic variant

ARB

SMM-align

PROPRED

 

Current 1

Old 2

current 1

old 2

current 1

old 2

HLA-DPA1*0103-DPB1*0201

0.823

 

0.921

   

HLA-DPA1*01-DPB1*0401

0.847

 

0.930

   

HLA-DPA1*0201-DPB1*0101

0.824

 

0.909

   

HLA-DPA1*0201-DPB1*0501

0.859

 

0.923

   

HLA-DPA1*0301-DPB1*0402

0.821

 

0.932

   

HLA-DQA1*0101-DQB1*0501

0.871

 

0.930

   

HLA-DQA1*0102-DQB1*0602

0.777

 

0.838

   

HLA-DQA1*0301-DQB1*0302

0.748

 

0.807

   

HLA-DQA1*0401-DQB1*0402

0.845

 

0.896

   

HLA-DQA1*0501-DQB1*0201

0.855

 

0.901

   

HLA-DQA1*0501-DQB1*0301

0.844

 

0.910

   

HLA-DRB1*0101

0.770

0.764

0.798

0.769

0.720

0.738

HLA-DRB1*0301

0.753

0.660

0.852

0.693

0.699

0.652

HLA-DRB1*0401

0.731

0.667

0.781

0.684

0.737

0.686

HLA-DRB1*0404

0.707

0.724

0.816

0.753

0.769

0.789

HLA-DRB1*0405

0.771

0.669

0.822

0.694

0.767

0.750

HLA-DRB1*0701

0.767

0.692

0.834

0.776

0.773

0.776

HLA-DRB1*0802

0.702

0.737

0.741

0.750

0.647

0.768

HLA-DRB1*0901

0.747

0.622

0.765

0.660

  

HLA-DRB1*1101

0.800

0.731

0.864

0.808

0.804

0.796

HLA-DRB1*1302

0.727

0.787

0.797

0.695

0.600

0.584

HLA-DRB1*1501

0.763

0.700

0.796

0.738

0.743

0.715

HLA-DRB3*0101

0.709

0.590

0.819

0.677

  

HLA-DRB4*0101

0.785

0.741

0.816

0.713

  

HLA-DRB5*0101

0.760

0.703

0.832

0.751

0.728

0.790

H-2-IAb

0.800

0.803

0.855

0.746

  

Average

0.784

0.706

0.849

0.727

0.726

0.731

Min

0.702

0.590

0.741

0.660

0.600

0.584

Max

0.871

0.803

0.932

0.808

0.804

0.796

  1. Best prediction performance for each allelic variant was highlighted in bold.
  2. 1. The current AUC values for ARB and SMM-align were derived by cross-validation. The current AUC values for PROPRED were derived by predicting affinities for the new dataset.
  3. 2. The old AUC values were taken from previous evaluation [30].